NovaBay Pharmaceuticals Inc.

NYSE American: NBY
Share price (1/3/25): $0.62
Market cap (1/3/25): $3.017 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from DEFA14A 87 pages Amendment No. 1 to Asset Purchase Agreement

from 8-K 87 pages Amendment No. 1 to Asset Purchase Agreement

from DEFA14A 3 pages Plan of Complete Liquidation and Dissolution of NovaBay Pharmaceuticals, Inc

from 8-K 3 pages Plan of Complete Liquidation and Dissolution of NovaBay Pharmaceuticals, Inc

from 8-K 83 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. the Redacted Terms Have Been Marked With the Following Marking: [Redacted.]

from DEFA14A 83 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. the Redacted Terms Have Been Marked With the Following Marking: [Redacted.]

from 8-K 45 pages Membership Unit Purchase Agreement

from 8-K 96 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. the Redacted Terms Have Been Marked With the Following Marking: [Redacted.]

from POS AM 5 pages Agreement and Plan of Merger of Novabay Pharmaceuticals, Inc. (A California Corporation) and Novabay Pharmaceuticals, Inc